Genotyping guided ripretinib directly after the progression of first-line imatinib therapy in advanced gastrointestinal stromal tumor: a case report

Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. Surgery and tyrosine kinase inhibitor (TKI) therapy are the main choices of treatment. However, the long-term use of TKIs is prone to drug resistance. Herein, we report the case of a 47-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shaoqing, Guo, Xiaodan, Xia, Yanzhe, Ding, Li, Zhai, Ertao, Chen, Sile, He, Yulong, Cai, Shirong, Zhang, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848389/
https://www.ncbi.nlm.nih.gov/pubmed/35282043
http://dx.doi.org/10.21037/atm-21-6960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848389/
https://www.ncbi.nlm.nih.gov/pubmed/35282043
http://dx.doi.org/10.21037/atm-21-6960

Ejemplares similares